Patent applications published 11 August 2010
Selected patent applications from the weekly European Patents Bulletin
- Compsn for administering an active ingredient and method for making and using the same
Innozen 2214478*
- Methods of treating non-alcoholic steato-hepatitis (NASH)_using cysteamine products
The Regents of the University of California 2214480*
- Prostaglandin analogue compsns and methods to treat epithelial-related conditions
Lipkin, Pamela 2214482*
- Methods of identifying histone deacetylase inhibitors useful for neurological disorders
Repligen 2214483*
- Process for the preparation of macrolide antibacterial agents
Cempra Pharmaceuticals 2214484*
- Methods for treatment of cancer
Minerva Biotechnology 2214485*
- Heteroaryl compounds and uses thereof
Avila Therapeutics 2214486*
- Novel SEH_inhibitors and their use
GlaxoSmithKline 2214487*
- Compsns and methods for treating Parkinson’s disease and related disorders
Kline, Ellis 2214488*
- Antimicrobiological coating, coating solution and method for manufacturing and reforming the coating
Millidyne 2214489*
- Quinolone analogues and methods related thereto
Cylene Pharmaceuticals 2214491*
- Acidic antibiotic compsns containing peracid and acetyl salicylic acid
Lee, Jin-Sik 2214492*
- Process for limiting the growth of microorganisms
3M Innovative Properties 2214493*
- Natural photodynamic agents and their use
Innovotech 2214495*
- Use of PHY906 as treatment for inflammatory bowel disease and/or irritable bowel syndrome
Phytoceutica 2214496*
- Uses and isolation of very small embryonic-like (VSEL) stem cells
University of Louisville Research Foundation 2214497*
- Solid formulations of crystalline compounds
Purdue Research Foundation 2214635*
- Oral dosage forms comprising licarbaz pine acetate
BIAL - Portela &_Ca 2214636*
- Stabilised paediatric suspension of carisbamate
Janssen Pharmaceutica 2214637*
- Compsn comprising polyunsaturated fatty acids and activated charcoal
Bayer Consumer Care 2214638*
- Anaesthetic compsn, formulation and method of use
Weg, Stuart 2214639*
- Intranasal compsns
Archimedes Development 2214640*
- A scalable matrix for the in vivo cultivation of bone and cartilage
Sivanthan, Surestan; Warnke, Patrick; Sherry, Eugene; Gopalakrishnan, Krish 2214641*
- Topical compsn
Novartis 2214642*
- Transdermal delivery system for hormones and steroids
Acrux 2214643*
- Water-immiscible materials as vehicles for drug delivery
Bausch &_Lomb 2214644*
- Liposomal vancomycin formulations
Transave 2214645*
- Dendrimers for sustained release of compounds
Wayne State University 2214646*
- Delivery of active agents
Mannkind Corp 2214647*
- Stabilised statins
Stada Arzneimittel 2214648*
- Compsns for treating Parkinson’s disease
Vectura 2214649*
- Bupropion hydrobromide and therapeutic applications
Biovail Laboratories 2214650*
- Nifedipine-containing press coated tablet and method of preparing the same
Bayer Yakuhin 2214651*
- Gastrointestinal delivery systems
Meritage Pharma 2214652*
- Pharmaceutical compsns containing statins and omega-3 fatty acids derivatives and their solid formulations for oral use
Zarmanian, Iervant 2214653*
- Method of encapsulation
The University of Manchester 2214654*
- Compsns containing resveratrol and pectin
DSM IP 2214655*
- Compsns and methods for enhancing immune response
Chemaphor; National Research Council of Canada 2214656*
- Compounds for treating demyelination conditions
UCB Pharma 2214657*
- Osmolyte-containing preparation for use in dry mucous membranes
Bitop 2214658*
- Use of 4-oxobutanoic acid derivatives in the treatment of pathologies associated with immunological disorders
Merck Patent 2214659*
- Omega-3 fatty acids, hydroxy polyunsaturated fatty acids, lipoxin compounds or oxylipin compounds for the treatment of ophthalmic conditions
Resolvyx Pharmaceuticals 2214660*
- Aqueous retinoid and benzoyl peroxide gel
Medicis Pharmaceutical Corp 2214661*
- Methods of using (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid in combination therapy
Sunesis Pharmaceuticals 2214662*
- Sphingosine-1-phosphate (S1P) receptor compounds
Universiteit Leiden 2214663*
- BRCA1-based breast or ovarian cancer prevention agents and methods of use
University of Kansas 2214664*
- Compounds for preventing or treating a viral infection
Institut Pasteur; Centre National de la Recherche Scientifique; INSERM_(Institut National de la Santé et de la Recherche Médicale) 2214665*
- Method of reducing mayloid deposition, amyloid neurotoxicity, and microgliosis with (-)-nilvadipine enantiomer
Alzheimers institute of America 2214666*
- Small molecule inhibitors of PARP_activity
Angion Biomedica 2214667*
- Novel antiretroviral combination
Cipla 2214668*
- Cytokine inhibitors
Hutchison Medipharma Enterprises 2214669*